Molecules, Mechanisms and Meanings

Dr Shelly guided us through the cutting edge of addiction medicine, including:

• The surprising potential of semaglutide and related agents in treating alcohol and methamphetamine dependence
• Early-stage but growing interest in psychedelic-assisted therapies for addiction, though longer-term data remains limited
• Emerging genetic research pointing to shared pathways between addiction, obesity, and liver disease
• Promising developments in medical devices, including wearable technology for opioid overdose detection
• And a unifying theme: collaboration, compassion, and hope in working with this highly vulnerable population

Her closing words resonated with us all:
“Know better, do better, be better.”